{"product_id":"retatrutide-10mg","title":"Retatrutide (RETA) – 10mg","description":"\u003cp\u003e\u003cstrong\u003eGLP-1 \/ GIP \/ Glucagon Triple Receptor Agonist | Obesity \u0026amp; Metabolic Research\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eRetatrutide is a next-generation acylated unimolecular triple agonist at GLP-1R, GIPR, and GCGR. Studied for obesity biology, appetite regulation, energy expenditure, glucagon-driven thermogenesis, and hepatic fat metabolism. Phase II data (NEJM, 2023) reported \u0026gt;24% mean body weight reduction in trial subjects.\u003c\/p\u003e\u003cp\u003e≥98.0% HPLC Purity  |  CAS: 2381016-49-5  |  MW: ~4,862 Da  |  Lyophilized Powder  |  Storage: −20°C\u003c\/p\u003e\u003cp\u003e\u003cem\u003e⚠ Research use only. Not approved for human or animal use. Not an approved medicine in Australia or globally. Unapproved therapeutic good — TGA, Australia.\u003c\/em\u003e\u003c\/p\u003e","brand":"Alpharma Peptide","offers":[{"title":"10mg","offer_id":47666797412588,"sku":"AP-RETA-10","price":99.99,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0831\/0905\/2652\/files\/Image-1_5eee73e4-48f6-4a55-9779-3d8dbfb01c9c.png?v=1779783037","url":"https:\/\/alpharmaaustralia.com\/products\/retatrutide-10mg","provider":"Alpharma Australia","version":"1.0","type":"link"}